Sign in

CIK 0000728387

  • Non-accelerated filer
  • Smaller reporting company

Perspective Therapeutics, Inc.

Sign in to watch
Ticker
CATX
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
411458152
Phone
+1 206-676-0900
Business address
2401 ELLIOTT AVENUE, SUITE 320, SEATTLE, WA, 98121
Former names
IsoRay, Inc., Isoray, Inc., CENTURY PARK PICTURES CORP
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4 Open-market buy Chief Executive Officer bought 26,676 shares at an average $2.24 ($59,673)
  6. 4 Open-market buy Director bought 60,337 shares at an average $2.19 ($132,151)
  7. 4 Open-market buy Chief Financial Officer bought 33,333 shares at $2.25 ($74,946)
  8. 4 Open-market buy Director bought 23,475 shares at $2.13 ($49,999)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market buy Director bought 25,975 shares at $3.85 ($100,004)
  19. 4 Open-market buy CEO bought 8,000 shares at $3.77 ($30,132)
  20. 4/A Insider Changes in Ownership

Page 2 of 17 · 338 filings